DMRA · NASDAQ
Damora Therapeutics (DMRA) Stock Price & Fundamentals
Damora Therapeutics (DMRA) closed at $543.81 on Oct 9, 2026, up 0.84% from the previous close of $539.29.
Share price, past year
1Y +10.21%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $543.81 |
| Sep 30, 2026 | $525.34 |
| Aug 31, 2026 | $525.08 |
| Jul 31, 2026 | $546.30 |
| Jun 30, 2026 | $535.36 |
| May 29, 2026 | $514.83 |
| Apr 30, 2026 | $511.60 |
| Mar 31, 2026 | $518.93 |
| Feb 27, 2026 | $499.22 |
| Jan 30, 2026 | $492.27 |
| Dec 31, 2025 | $492.80 |
| Nov 28, 2025 | $492.57 |
| Oct 31, 2025 | $481.13 |
Key statistics
- Market cap
- $33.57B
- P/E (TTM)
- 72.6
- EPS (TTM)
- $7.49
- Net income (TTM)
- −$262.83M
- Shares outstanding
- 61.7M
- 52-week range
- $470.24 – $554.47
Damora Therapeutics's market cap is $33.57B, based on a share price of $543.81 and 61.7M shares outstanding as of Jun 30, 2026.
Financials
Damora Therapeutics's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
Damora Therapeutics reported a net loss of $209.84M in fiscal 2025.
Company profile
- Name
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 221 Crescent Street, Building 23, Suite 105, Waltham, MA 02453
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001800315
Recent SEC filings
- Aug 10, 2026
- Jul 20, 2026
- Jun 17, 2026
- May 12, 2026
- May 4, 2026
- Apr 20, 2026
- Mar 23, 2026
- Mar 19, 2026
Frequently asked questions
What is Damora Therapeutics's stock price?
Damora Therapeutics (DMRA) closed at $543.81 on Oct 9, 2026, up 0.84% from the previous close of $539.29.
What is Damora Therapeutics's market cap?
Damora Therapeutics's market cap is $33.57B, based on a share price of $543.81 and 61.7M shares outstanding as of Jun 30, 2026.
What is DMRA's P/E ratio?
Damora Therapeutics's price-to-earnings ratio is 72.6, based on trailing twelve-month diluted EPS of $7.49.
Does Damora Therapeutics pay a dividend?
Yes. Damora Therapeutics declared $0.00 per share in dividends for fiscal 2025.
Sources and methodology
Fundamentals come from Damora Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures